Takeda Pharmaceutical Company Limited (TAK)
USD 13.11
(-1.87%)
USD 13.11
(-1.87%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 5463.39 Billion JPY | 24.67% |
| 2023 | 4382.34 Billion JPY | 0.85% |
| 2022 | 4345.41 Billion JPY | -6.26% |
| 2021 | 4635.37 Billion JPY | -8.99% |
| 2020 | 5093.3 Billion JPY | -11.44% |
| 2019 | 5750.95 Billion JPY | 483.46% |
| 2018 | 985.66 Billion JPY | -13.91% |
| 2017 | 1144.89 Billion JPY | 49.03% |
| 2016 | 768.22 Billion JPY | 5.33% |
| 2015 | 729.38 Billion JPY | -15.19% |
| 2014 | 859.98 Billion JPY | 54.17% |
| 2013 | 557.81 Billion JPY | -0.84% |
| 2012 | 562.56 Billion JPY | 3313.2% |
| 2011 | 16.48 Billion JPY | -12.35% |
| 2010 | 18.8 Billion JPY | -4.86% |
| 2009 | 19.76 Billion JPY | 238.95% |
| 2008 | 5.83 Billion JPY | -49.81% |
| 2007 | 11.61 Billion JPY | -7.69% |
| 2006 | 12.58 Billion JPY | -31.98% |
| 2005 | 18.5 Billion JPY | 26.4% |
| 2004 | 14.63 Billion JPY | 16.59% |
| 2003 | 12.55 Billion JPY | 5.18% |
| 2002 | 11.93 Billion JPY | -25.85% |
| 2001 | 16.09 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 FY | 5463.39 Billion JPY | 24.67% |
| 2024 Q4 | 5463.39 Billion JPY | 17.14% |
| 2024 Q3 | 4664.16 Billion JPY | -0.32% |
| 2024 Q1 | 4747.11 Billion JPY | 13.16% |
| 2024 Q2 | 4679.2 Billion JPY | -7.84% |
| 2023 Q3 | 4286.9 Billion JPY | -9.49% |
| 2023 Q2 | 4736.64 Billion JPY | 2.92% |
| 2023 FY | 4382.34 Billion JPY | 0.85% |
| 2023 Q1 | 4602.25 Billion JPY | 5.91% |
| 2023 Q4 | 4382.34 Billion JPY | 2.23% |
| 2022 Q3 | 4354.87 Billion JPY | 2.92% |
| 2022 Q1 | 4405.86 Billion JPY | -4.95% |
| 2022 Q2 | 4231.35 Billion JPY | -3.96% |
| 2022 FY | 4345.41 Billion JPY | -6.26% |
| 2022 Q4 | 4345.41 Billion JPY | -0.22% |
| 2021 Q1 | 5074.95 Billion JPY | -0.36% |
| 2021 FY | 4635.37 Billion JPY | -8.99% |
| 2021 Q2 | 4908.03 Billion JPY | -3.29% |
| 2021 Q4 | 4635.37 Billion JPY | -2.43% |
| 2021 Q3 | 4751.04 Billion JPY | -3.2% |
| 2020 Q2 | 5024.61 Billion JPY | -11.11% |
| 2020 Q1 | 5652.64 Billion JPY | -1.71% |
| 2020 Q3 | 5221.75 Billion JPY | 3.92% |
| 2020 Q4 | 5093.3 Billion JPY | -2.46% |
| 2020 FY | 5093.3 Billion JPY | -11.44% |
| 2019 Q4 | 5750.95 Billion JPY | 125.64% |
| 2019 Q2 | 1000.53 Billion JPY | 0.56% |
| 2019 Q1 | 994.97 Billion JPY | 0.94% |
| 2019 FY | 5750.95 Billion JPY | 483.46% |
| 2019 Q3 | 2548.78 Billion JPY | 154.74% |
| 2018 Q4 | 985.66 Billion JPY | -13.42% |
| 2018 FY | 985.66 Billion JPY | -13.91% |
| 2018 Q3 | 1138.46 Billion JPY | 0.1% |
| 2018 Q2 | 1137.35 Billion JPY | -0.65% |
| 2018 Q1 | 1144.84 Billion JPY | -0.0% |
| 2017 Q4 | 1144.89 Billion JPY | 17.32% |
| 2017 Q3 | 975.89 Billion JPY | 2.59% |
| 2017 Q1 | 954.4 Billion JPY | 24.24% |
| 2017 Q2 | 951.26 Billion JPY | -0.33% |
| 2017 FY | 1144.89 Billion JPY | 49.03% |
| 2016 Q2 | 729.03 Billion JPY | -0.56% |
| 2016 Q4 | 768.22 Billion JPY | 5.22% |
| 2016 FY | 768.22 Billion JPY | 5.33% |
| 2016 Q3 | 730.11 Billion JPY | 0.15% |
| 2016 Q1 | 733.15 Billion JPY | 0.52% |
| 2015 Q3 | 912.87 Billion JPY | 3.72% |
| 2015 Q1 | 855.91 Billion JPY | -0.47% |
| 2015 Q4 | 729.38 Billion JPY | -20.1% |
| 2015 Q2 | 880.15 Billion JPY | 2.83% |
| 2015 FY | 729.38 Billion JPY | -15.19% |
| 2014 Q4 | 859.98 Billion JPY | 8.65% |
| 2014 FY | 859.98 Billion JPY | 54.17% |
| 2014 Q3 | 791.5 Billion JPY | 0.01% |
| 2014 Q2 | 791.41 Billion JPY | 46.11% |
| 2014 Q1 | 541.64 Billion JPY | -2.9% |
| 2013 Q4 | 557.81 Billion JPY | 2.94% |
| 2013 FY | 557.81 Billion JPY | -0.84% |
| 2013 Q1 | 542.8 Billion JPY | -3.51% |
| 2013 Q2 | 541.8 Billion JPY | -0.18% |
| 2013 Q3 | 541.87 Billion JPY | 0.01% |
| 2012 Q3 | 541.26 Billion JPY | -5.26% |
| 2012 Q4 | 562.56 Billion JPY | 3.94% |
| 2012 FY | 562.56 Billion JPY | 3313.2% |
| 2012 Q1 | 1.27 Billion JPY | -92.29% |
| 2012 Q2 | 571.33 Billion JPY | 44887.01% |
| 2011 Q2 | 2.99 Billion JPY | -2.16% |
| 2011 Q3 | 3.2 Billion JPY | 6.99% |
| 2011 Q4 | 16.48 Billion JPY | 414.9% |
| 2011 FY | 16.48 Billion JPY | -12.35% |
| 2011 Q1 | 3.05 Billion JPY | -83.74% |
| 2010 Q4 | 18.8 Billion JPY | 475.93% |
| 2010 Q3 | 3.26 Billion JPY | 5.29% |
| 2010 Q2 | 3.1 Billion JPY | 0.0% |
| 2010 FY | 18.8 Billion JPY | -4.86% |
| 2009 FY | 19.76 Billion JPY | 238.95% |
| 2009 Q4 | 19.76 Billion JPY | 434.31% |
| 2009 Q3 | 3.69 Billion JPY | 0.0% |
| 2008 FY | 5.83 Billion JPY | -49.81% |
| 2007 FY | 11.61 Billion JPY | -7.69% |
| 2006 FY | 12.58 Billion JPY | -31.98% |
| 2005 FY | 18.5 Billion JPY | 26.4% |
| 2004 FY | 14.63 Billion JPY | 16.59% |
| 2003 FY | 12.55 Billion JPY | 5.18% |
| 2002 FY | 11.93 Billion JPY | -25.85% |
| 2001 FY | 16.09 Billion JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 2.75 Billion USD | -198530.988% |
| Bausch Health Companies Inc. | 22.38 Billion USD | -24303.212% |
| Catalent, Inc. | 4.98 Billion USD | -109430.694% |
| Emergent BioSolutions Inc. | 877.5 Million USD | -622508.661% |
| Elanco Animal Health Incorporated | 5.77 Billion USD | -94520.558% |
| Perrigo Company plc | 4.07 Billion USD | -134023.607% |
| Teva Pharmaceutical Industries Limited | 20.15 Billion USD | -27009.567% |
| Zoetis Inc. | 6.8 Billion USD | -80208.555% |